Stem Cell Research and News: Georgia
<-- Back To RegionsViaCell Reports Success With Heart Treatment Stem Cell Therapy
Well known stem cell research firm ViaCell is reporting that Unrestricted Somatic Stem Cells (USSCs), which are pluripotent stem cells and can be collected human cord blood, have been tested in a small animal model of myocardial infarction .. ie...
Posted in Today's Stem Cell Research on March 14, 2006 02:58 PM
Adult Stem Cells Aid Recovery In Animal Model Of Cerebral Palsy
Researchers report that a recent study, run at Medical College of Georgia, shows the adult stem cell therapy quickly and significantly improving the recovery of motor function in an animal model for the ischemic brain injury that occurs in about...
Posted in Today's Stem Cell Research on October 21, 2005 06:43 PM
AnorMED to Seek Conditional Marketing Authorization in Europe for MOZOBIL, a New Stem Cell Mobilizer
Clinical Results from MOZOBIL Compassionate Use Program in Stem Cell Transplant Accepted for Oral Presentation at the American Society of Hematology Meeting in Atlanta, Georgia VANCOUVER, British Columbia, October 18, 2005 /PRNewswire-FirstCall/ - AnorMED Inc. announced today that it will...
Posted in Today's Stem Cell Research on October 18, 2005 06:19 PM
Stem Cell Therapy International Engages the Cutler Law Group
TAMPA, Fla. - Sept. 22, 2005 - Stem Cell Therapy International, Inc., (ATYD), a company in the field of regenerative medicine that specializes in the treatment of patients with stem cell transplantation therapy as well as being a global supplier...
Posted in Today's Stem Cell Research on October 4, 2005 05:46 PM
Markers Of Brain Cell Development May Help Success Of Stem Cell Transplants
Four sugar-coated faces made by stem cells as they differentiate into brain cells during development have been identified by scientists. These unique expressions of sugar on the cell surface may one day enable stem cell therapy to repair brain injury...
Posted in Today's Stem Cell Research on September 22, 2005 04:33 PM
Serologicals Corporation to Receive Start Magazine’s 2005
President & CEO David A. Dodd, Previously Named One of Start’s CEO Visionaries, Featured Speaker at Manufacturing Conference ATLANTA, GA – August 9, 2005 – Serologicals Corporation (NASDAQ: SERO) announced today that it has been awarded an Editor’s Choice Technology...
Posted in Today's Stem Cell Research on August 9, 2005 05:54 PM
Serologicals Corporation to Present at Banc of America 2005 Healthcare Conference
Serologicals Corporation (Nasdaq/NM: SERO) today announced that it is scheduled to give an investor presentation at the Banc of America 2005 Healthcare Conference on May 17, 2005. Bud Ingalls, Vice President, Finance and Chief Financial Officer for Serologicals Corporation, will...
Posted in Today's Stem Cell Research on May 13, 2005 01:45 PM
ThermoGenesis Corp. to Present at SunTrust Robinson Humphrey's Annual Conference
RANCHO CORDOVA, Calif., April 11 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a pioneer in the development of systems that enable the production and storage of therapeutic components, today announced that Chairman and Chief Executive Officer, Philip H. Coelho, will be...
Posted in Today's Stem Cell Research on April 11, 2005 03:27 PM
David A. Dodd Awarded 2005 Oglethorpe Sword By British American Business Group of Atlanta
Atlanta - March 16, 2005 - Serologicals Corporation (NASDAQ: SERO) announced today that David A. Dodd, President and Chief Executive Officer, has recently been awarded the prestigious Oglethorpe Sword, a ceremonial broad sword given annually to an American or British...
Posted in Today's Stem Cell Research on March 17, 2005 01:03 PM
Research Crunch at University of Washington
In a University of Washington laboratory gleaming with stainless steel, Kristen Helton carefully dips a pipette into neat rows of tiny vials. She's testing spit, trying to figure out how to use saliva instead of blood for medical tests. It's...
Posted in Today's Stem Cell Research on February 17, 2005 01:59 PM
Stem Cells' Promise Pits Jobs vs. Values
stem cell research,stem cell,biotech,biotech industry,biotech jobs,embryonic stem cell research,embryonic stem cell,embryo,biotechs,bill banning,stem cells
Posted in Today's Stem Cell Research on February 16, 2005 02:31 PM
Stem Cell Research Programs at Universities Around the World.
After reading around, and trying to get some resources in place for Stem Cell Research references and news sources, we decided to get a list of University Medical Programs that participate in or are part of the Stem Cell Research...
Posted in Today's Stem Cell Research on January 14, 2005 12:29 PM
Chemicon and Thromb-X N.V., the R&D Division of ThromboGenics Ltd., Enter Into Agreement for Exclusive Sale and Marketing of New Embryonic Stem Cell Tissue Culture Media
ATLANTA, GA and LEUVEN, BELGIUM – October 26, 2004 – Thromb-X N.V., the R&D division of ThromboGenics Ltd., and Chemicon International, a division of Serologicals Corporation (NASDAQ/NM: SERO), today announced the signing of an exclusive global agreement to market embryonic...
Posted in Today's Stem Cell Research on December 28, 2004 02:38 PM
University of Georgia Gets NIH Grant for Stem Cell Research
Researchers at the University of Georgia have been awarded a grant of $425,598 subcontract to develop human embryonic stem cell-derived tests for screening drugs capable of treating spinal muscular atrophy (SMA), the number one genetic killer of children under the...
Posted in Today's Stem Cell Research on December 15, 2004 11:37 AM
Latest Finding Could Improve Safety of Stem Cell Transplants
A certain type of lipid that helps destroy potentially harmful cells during brain development shows potential promise for improving the safety and efficacy of stem cell transplants, say researchers at the Medical College of Georgia and University of Georgia. When...
Posted in Today's Stem Cell Research on December 10, 2004 08:26 AM
New Research Could Improve Safety of Stem Cell Transplants
Researchers at the Medical College of Georgia and University of Georgia have found that a lipid, ceramide, helps eliminate cells that could later form tumors called teratomas, researchers say in the Nov. 22 issue of The Journal of Cell Biology.......
Posted in Today's Stem Cell Research on November 29, 2004 11:52 PM
Umbilical Cord Blood-Derived Stem Cells Given Intravenously Reduce Stroke Damage
Stem cells from umbilical cord blood, then given intravenously combined with a drug designed to temporarily breach the brain's blood barrier, has been shown to dramatically reduce a stroke's size and damage, Medical College of Georgia and University of South...
Posted in Today's Stem Cell Research on November 27, 2004 09:07 AM